Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Parsons
Antipsychotic Drugs Antagonize Human Serotonin Type 3 Receptor Currents in a Noncompetitive Manner
Molecular Psychiatry
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
Near Drowning.
BMJ
Related publications
Serotonin Receptor Diversity in the Human Colon: Expression of Serotonin Type 3 Receptor Subunits 5-Ht3c, 5-Ht3d, and 5-Ht3e
Journal of Comparative Neurology
Neuroscience
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Determining Receptor–ligand Interaction of Human Galanin Receptor Type 3
Neurochemistry International
Molecular Neuroscience
Cell Biology
Cellular
Thiazolidinedione Drugs Down-Regulate CXCR4 Expression on Human Colorectal Cancer Cells in a Peroxisome Proliferator Activated Receptor Γ-Dependent Manner
International Journal of Oncology
Cancer Research
Oncology
Reduced Serotonin Type 1A Receptor Binding in Panic Disorder
Journal of Neuroscience
Neuroscience
Serotonin Hormonally Regulates Lacrimal Gland Secretory Function via the Serotonin Type 3a Receptor
Scientific Reports
Multidisciplinary
Antipsychotic Drugs on Maternal Behavior in Rats
Behavioural Pharmacology
Psychiatry
Mental Health
Pharmacology
Menstrual Changes With Antipsychotic Drugs
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
The Serotonin Type 3 Receptor Antagonist BRL 43694 and Nausea and Vomiting Induced by Cisplatin.
BMJ